Dosidal · Switzerland

Insulin NovoNordisk NovoRapid, Injektionslösung

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:55045 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 55045
atc: A10AB05
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 1999-06-15
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: A10AB05
authorisation_number: 55045
form: LSIMD
holder: Novo Nordisk Pharma AG
holder_partner_nr: 1000306
it_number: 07.06.1.
name: Insulin NovoNordisk NovoRapid, Injektionslösung
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
Bcu36KuGQmbfqGjnrDW6C-nbHXvgaamVViMe9imvbXeXInJJxjgJMhrtZHLnOZQUufzsBx2k21RtMbBI6Pg8JA
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

Dosidal